KRT17 and uterine cervix carcinoma in situ: This result is nearly analogous to that obtained earlier (55),who found IHC expression of CK17 in 33.3% of CIN-I, 58.1% of CIN-II, 81.4% of CIN-III and in 95.2% of squamous cell carcinoma.